Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

Hepatology

Volumn 30, Issue 3, 1999, Pages 779-786

  Ogata, Norio ^a,b   Cote, Paul J ^c   Zanetti, Alessandro R ^d   Miller, Roger H ^a   Shapiro, Max ^e   Gerin, John ^c   Purcell, Robert H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e BIOQUAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHIMPANZEE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; VIRUS MUTANT;

ANIMALS; CODON; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; MUTATION; PAN TROGLODYTES; VACCINATION; VACCINES, SYNTHETIC;

EID: 0032822193     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300309     Document Type: Article

References (28)

1. Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, et al. Hepatitis B variant in Europe. Lancet 1988;ii:1132-1133.
2. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
3. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991;13(Suppl 4):S105-S107.
4. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992;184:1152-1157.
5. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatric Res 1992;32:264-268.
6. Zuckerman AJ, Harrison TJ, Oon C-J. Mutations in S region of hepatitis B virus. Lancet 1994;343:737-738.
7. Oon C-J, Lim G-K, Ye Z, Goh K-T, Tan K-L, Yo S-L, Hopes E, Harrison TJ, Zuckerman AJ. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995;13:699-702.
8. Oon C-J, Tan K-L, Harrison T, Zuckerman A. Natural history of hepatitis B surface antigen mutants in children. Lancet 1996;348:1524.
9. Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994;169:1374-1376.
10. Karthigesu VD, Allison LMC, Fortuin M, Mendy M, Whittle HC, Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994;75:443-448.
11. Hino K, Okuda M, Hashimoto O, Ishiko H, Okazaki M, Fujii K, Hanada H, Okita K. Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci 1995;40:566-570.
12. Ho M-S, Lu C-F, Kuo J, Mao Y-C, Chao W-H. A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children. Clin Diagn Lab Immunol 1995;2:760-762.
13. Ni F, Fang D, Gan R, Li Z, Duan S, Xu Z. A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. Res Virol 1995;146:397-407.
14. Surya IGP, Kishimoto S, Sudaryat S, Tsuda F, Hamid A, Takahashi K, Suwignyo S, et al. Prevention of mother-to-infant transmission of hepatitis B virus with use of a preS2-containing vaccine in Bali, Indonesia. Vaccine Res 1996;5:203-213.
15. Hsu H-Y, Chang M-H, Ni Y-H, Lin H-H, Wang S-M, Chen D-S. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. HEPATOLOGY 1997;26:786-791.
16. Lee P-I, Chang L-Y, Lee C-Y, Huang L-M, Chang M-H. Detection of hepatitis B surface antigen gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 1997;176:427-430.
17. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997;176:1360-1365.
18. Chiou H-L, Lee T-S, Kuo J, Mau Y-C, Ho M-S. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol 1997;78:2639-2645.
19. Matsumoto T, Nakata K, Hamasaki K, Daikokoku M, Nakao K, Yamashita Y, Shirahama S, et al. Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction. J Med Virol 1997;53:255-260.
20. McIntosh EDG, Givney R, Zhang S-S, Courouce A-M, Burgess M, Cossart YE. Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia. J Med Virol 1998;56:10-17.
21. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. HEPATOLOGY 1992;15:757-766.
22. Cariani E, Ravaggi A, Tanzi E, Romano L, Fiordalisi G, Bellati G, Caccamo L, et al. Emergence of hepatitis B virus S gene mutant in a liver transplant recipient. Med Virol 1995;47:410-415.
23. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. HEPATOLOGY 1996;24:489-493.
24. Hawkins AE, Gilson RJC, Gilbert N, Wreghitt TG, Gray JJ, de Boer IA, Tedder RS, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996;24:8-14.
25. Brind A, Jiang J, Samuel D, Gigou M, Feray C, Brechet C, Kremsdorf D. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 1997;26: 228-235.
26. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok ASF. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. HEPATOLOGY 1998;27:213-222.
27. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde K-HM, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. HEPATOLOGY 1998;27:254-263.
28. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane K, Yotsumoto S, Okamoto H, et al. Naturally occurring escape mutant of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-2676.